News and Views


Nature Chemical Biology 2, 295 - 296 (2006)
doi:10.1038/nchembio0606-295

Signalomic signatures enlighten drug profiling

Robert T Abraham1

  1. Robert T. Abraham is in the Department of Oncology Discovery, Wyeth, 401 N. Middletown Road, Pearl River, New York 10965, USA. e-mail: abrahar@wyeth.com.


When introduced into living cells, drugs frequently evoke unanticipated responses that are due either to off-target effects or to previously unknown interactions between the intended target and other biochemical pathways. The development of a panel of high-resolution sentinel assays for signal-transduction cascades in human cells promises to enhance the power of chemical genetics and increase the efficiency of drug-discovery research.

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

RESEARCH

Identifying off-target effects and hidden phenotypes of drugs in human cells

Nature Chemical Biology Article (01 Jun 2006)


Extra navigation

Subscribe to Nature Chemical Biology

Subscribe

Search PubMed for

Open Innovation Challenges